AAN issues review of evidence for aducanumab in Alzheimer’s disease
Mar 03, 2022
A class I study shows that single doses of aducanumab are safe and well-tolerated; class II studies show reduced amyloid deposition on brain PET at one year.
Researchers use virtual reality to help develop dementia test
By
Lois A. Bowers
Sep 05, 2017
Scientists are asking the players of virtual reality games to play a free game to help them better understand dementia, with the goal of developing a diagnostic test. A mobile version is available, too.
Risk for incident dementia up with pro-inflammatory diet
Nov 22, 2021
Individuals in the highest versus lowest diet inflammatory index tertile were three times more likely to develop dementia.
The latest findings on drinking and dementia are causing quite a buzz
By
John O'Connor
Mar 08, 2018
Here’s the problem I have with so many new studies: It seems that every one of them is soon offset by a different investigation that serves up a very different message.
Social isolation may be independent risk factor for dementia
Jun 10, 2022
Lower gray matter volumes in temporal, frontal, other regions were seen in socially isolated individuals.
Levetiracetam well-tolerated for Alzheimer’s disease
Oct 01, 2021
It does not improve primary outcome but did improve performance on certain cognitive tasks in those with epileptiform activity.
Blood tests and phone apps: The future of diagnosing Alzheimer’s?
By
Lois A. Bowers
Apr 08, 2019
Last week in a blog post, Bill Gates shared some exciting ways that Alzheimer’s disease might be diagnosed in the future.
Dementia incidence varies by race, ethnicity
Apr 21, 2022
Among U.S. veterans, the rates of dementia were highest for Blacks and Hispanics.
Rehospitalization in dementia patients tied to nurse continuity
Jun 28, 2021
Wide variation was seen in continuity of nursing staff for home healthcare visits to dementia patients following hospitalization.
Pricey Alzheimer drug drives spike in Medicare B premium: Officials
Nov 15, 2021
New premium will be $170.10 a month, and the $21.60 boost is the biggest increase ever in dollar amount, but not in percentage terms